Pfizer Stock Analysis

PFE -  USA Stock  

USD 50.65  0.25  0.50%

The latest indifference towards the small price fluctuations of Pfizer Inc may encourage shareholders to take a closer look at the company as it is trading at a share price of 50.65 on 19,860,451 in trading volume. The company directors and management did not add any value to Pfizer investors in April. However, most investors can still diversify their portfolios with Pfizer Inc to hedge their inherited risk against high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 1.87. The below-average Stock volatility is a good sign for longer-term investment options and for buy-and-hold investors.
Please check Your Equity Center.
  
Refresh
The Pfizer stock analysis report makes it easy to digest most publicly released information about Pfizer and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Pfizer Stock analysis module also helps to analyze the Pfizer price relationship with some important fundamental indicators such as market cap and management efficiency.

Pfizer Stock Analysis Notes

About 70.0% of the company shares are owned by institutional investors. The book value of Pfizer was at this time reported as 13.49. The company next dividend is scheduled to be issued on the 12th of May 2022. Pfizer Inc had 3:1 split on the 17th of November 2020. Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. Pfizer operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 79000 people. To find out more about Pfizer Inc contact Ian Read at 212 733 2323 or learn more at https://www.pfizer.com.

Pfizer Inc Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Pfizer's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Pfizer Inc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
About 70.0% of the company shares are owned by institutional investors
Latest headline from www.fool.com: Acquisition by Jennifer Damico of tradable shares of Pfizer subject to Rule 16b-3

Pfizer Inc Upcoming and Recent Events

Earnings reports are used by Pfizer to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Pfizer previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report8th of February 2022
Next Financial Report3rd of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End8th of February 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Pfizer Largest EPS Surprises

Earnings surprises can significantly impact Pfizer's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
1999-07-19
1999-06-300.170.190.0211 
1998-10-13
1998-09-300.190.17-0.0210 
1998-07-09
1998-06-300.150.170.0213 
View All Earnings Estimates

Pfizer Thematic Classifications

In addition to having Pfizer stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Robots And Drones IdeaRobots And Drones
Cross-sector firms and funds that develop or invest in technology that can replicate repetitive human actions
Healthcare IdeaHealthcare
USA Equities from Healthcare industry as classified by Fama & French
Drugs IdeaDrugs
Drug manufacturing and delivery

Pfizer Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Pfizer is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Pfizer Inc backward and forwards among themselves. Pfizer's institutional investor refers to the entity that pools money to purchase Pfizer's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Vanguard Group IncCommon Shares479.1 M24.8 B
Blackrock IncCommon Shares408.1 M21.1 B
State Street CorpCommon Shares286.9 M14.9 B
Capital World InvestorsCommon Shares219.9 M11.4 B
Wellington Management Group LlpCommon Shares216.7 M11.2 B
Geode Capital Management LlcCommon Shares104.9 M5.4 B
Northern Trust CorpCommon Shares66.5 M3.4 B
Note, although Pfizer's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Pfizer Market Capitalization

The company currently falls under 'Mega-Cap' category with total capitalization of 284.29 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pfizer's market, we take the total number of its shares issued and multiply it by Pfizer's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Pfizer Profitablity

Pfizer's profitability indicators refer to fundamental financial ratios that showcase Pfizer's ability to generate income relative to its revenue or operating costs. If, let's say, Pfizer is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Pfizer's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Pfizer's profitability requires more research than a typical breakdown of Pfizer's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of 27.04 %, which may imply that it executes well on its competitive polices and has reasonable control over its expenses and variable costs. This is very large. In the same way, it shows Net Operating Margin of 39.3 %, which entails that for every 100 dollars of revenue, it generated 0.39 of operating income.

Management Efficiency

The entity has Return on Asset of 10.0 % which means that on every $100 spent on asset, it made $10.0 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 31.87 %, implying that it generated $31.87 on every 100 dollars invested. Pfizer management efficiency ratios could be used to measure how well pfizer inc manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 19th of May, Pfizer holds the Semi Deviation of 1.53, coefficient of variation of 3918.43, and Risk Adjusted Performance of 0.0372. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pfizer, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for Pfizer Inc, which can be compared to its competitors. Please check Pfizer Inc information ratio, as well as the relationship between the value at risk and expected short fall to decide if Pfizer Inc is priced some-what accurately, providing market reflects its current price of 50.65 per share. Given that Pfizer has jensen alpha of 0.1299, we recommend you to check out Pfizer Inc's recent market performance to make sure the company can sustain itself at a future point.

Pfizer Inc Price Movement Analysis

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Simple Moving Average indicator is calculated by adding the closing price of Pfizer for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Pfizer Inc short-term fluctuations and highlight longer-term trends or cycles.
.

Pfizer Inc Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Pfizer insiders, such as employees or executives, is commonly permitted as long as it does not rely on Pfizer's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Pfizer insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Pfizer Predictive Daily Indicators

Pfizer intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Pfizer stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Pfizer Forecast Models

Pfizer time-series forecasting models is one of many Pfizer's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Pfizer's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Pfizer Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Pfizer stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Pfizer shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Pfizer. By using and applying Pfizer Stock analysis, traders can create a robust methodology for identifying Pfizer entry and exit points for their positions.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and womens health under the Premarin family and Eliquis brands biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the ComirnatyBNT162b2, Nimenrix, FSMEIMMUN-TicoVac, Trumenba, and the Prevnar family brands biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, EucrisaStaquis, and Cibinqo brands and amyloidosis, hemophilia, and endocrine diseases under the VyndaqelVyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company Astellas Pharma US, Inc. Myovant Sciences Ltd. Akcea Therapeutics, Inc Merck KGaA Valneva SE BioNTech SE and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Current Pfizer Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Pfizer analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Pfizer analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
58.92Buy13Odds
Pfizer Inc current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Pfizer analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Pfizer stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Pfizer Inc, talking to its executives and customers, or listening to Pfizer conference calls.
Pfizer Analyst Advice Details

Pfizer Stock Analysis Indicators

Pfizer Inc stock analysis indicators help investors evaluate how Pfizer stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Pfizer shares will generate the highest return on investment. By understating and applying Pfizer stock analysis, traders can identify Pfizer position entry and exit signals to maximize returns.
Quick Ratio1.10
Trailing Annual Dividend Rate1.55
Fifty Two Week Low38.48
Revenue Growth106.80%
Payout Ratio35.36%
Average Daily Volume Last 10 Day24.78M
Shares Short Prior Month61.56M
Average Daily Volume In Three Month28.17M
Earnings Growth291.10%
Shares Percent Shares Out1.20%
Earnings Quarterly Growth301.10%
Gross Margins62.28%
Forward Price Earnings9.78
Short Percent Of Float1.20%
Float Shares5.62B
Fifty Two Week High61.71
Fifty Day Average51.22
Enterprise Value To Ebitda8.97
Two Hundred Day Average49.75
Enterprise Value To Revenue3.53
Trailing Annual Dividend Yield3.08%
Please check Your Equity Center. Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Complementary Tools for Pfizer Stock analysis

When running Pfizer Inc price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Is Pfizer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine Pfizer value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.